Revvity, Inc., announced today the launch of the in-vitro diagnostic EURORealTime™ APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene.

A new study from Stanford Medicine suggests that glucose plays a surprising role in the aging brain's ability to produce new ...

The largest and most diverse study to date of epilepsy's genetic factors has revealed new potential targets for treatment, ...

Arrowhead's plozasiran shows promising Phase 3 data for FCS, with potential blockbuster status, but faces competition. Learn ...

A revolutionary milestone in dentistry and genetics has set the stage for transformative medical treatments. The team of ...

How long someone has left to live can be calculated by taking a simple mouth swab, according to a new study. Scientists say a ...

A world's first vaccine for deadly ovarian cancer currently being developed in the UK could eradicate the deadly disease, ...

Discover which hepatocytes are suitable for various study types and learn why hepatocytes are critical for ADME/DMPK ...

Chinese biotech firms WuXi AppTec and WuXi Biologics are exploring the sale of certain operations in response to potential ...

Being diagnosed with breast cancer is overwhelming. But, during the monthlong National Breast Cancer Awareness campaign which ...